← Back to headlines
Sanofi Exceeds Q1 Estimates Driven by Dupixent Sales
Pharmaceutical company Sanofi reported first-quarter earnings that topped analyst estimates, primarily due to strong sales of its drug Dupixent, and reaffirmed its full-year outlook.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
